Search results

122 results

Sorted by Relevance . Sort by Date

Guidance Remove Guidance filter
In development Remove In development filter
Proposed Remove Proposed filter
Interventional procedures guidance Remove Interventional procedures guidance filter
Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
Public health guidelines Remove Public health guidelines filter
Safe staffing guidelines Remove Safe staffing guidelines filter

Tobacco: preventing uptake, promoting quitting and treating dependence (update)

In development [GID-NG10086] Expected publication date: 01 September 2021

Type

NICE guideline

Status

In development
Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818

Proposed [GID-HST10040] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
Lenti-D for treating cerebral adrenoleukodystrophy [ID1284]

Proposed [GID-HST10038] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
VTS-270 for treating Niemann-Pick type C1 (ID1267)

Proposed [GID-HST10020] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
Setmelanotide for treating obesity caused by LEPR or POMC deficiency [ID3764]

Proposed [GID-HST10034] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

Proposed [GID-HST10019] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
Lonafarnib for treating progeria and progeroid laminopathies [ID3867]

Proposed [GID-HST10039] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
Avalglucosidase alfa for treating Pompe disease [ID3737]

Proposed [GID-HST10030] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]

Proposed [GID-HST10037] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]

Proposed [GID-HST10022] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

Proposed
OTL-200 for treating metachromatic leukodystrophy [ID1666]

In development [GID-HST10028] Expected publication date: 13 August 2021

Type

Highly specialised technologies guidance

Status

In development
Givosiran for treating acute hepatic porphyria [ID1549]

In development [GID-HST10035] Expected publication date: 04 August 2021

Type

Highly specialised technologies guidance

Status

In development
Elosulfase alfa for treating mucopolysaccharidosis type IVa (review of HST2) [ID1643]

In development [GID-HST10027] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Metreleptin for treating lipodystrophy (ID861)

In development [GID-HST10011] Expected publication date: 24 February 2021

Type

Highly specialised technologies guidance

Status

In development
Velmanase alfa for treating alpha-mannosidosis [ID800]

In development [GID-HST10010] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Human alpha1-proteinase inhibitor for treating emphysema ID856

In development [GID-HST10017] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Lysosomal acid lipase deficiency - sebelipase alfa [ID737]

In development [GID-LYSOSOMALACIDLIPASEDEFICIENCYSEBELIPASEALFAID737] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Afamelanotide for treating erythropoietic protoporphyria [ID927]

In development [GID-HST10009] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Onasemnogene abeparvovec for treating spinal muscular atrophy type 1 [ID1473]

In development [GID-HST10026] Expected publication date: 25 March 2021

Type

Highly specialised technologies guidance

Status

In development
Palovarotene for preventing heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID3739]

In development [GID-HST10032] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]

In development [GID-HST10033] Expected publication date: TBC

Type

Highly specialised technologies guidance

Status

In development
Vaccine uptake in the general population

In development [GID-NG10139] Expected publication date: 06 April 2022

Type

NICE guideline

Status

In development
Looked-after children and young people

In development [GID-NG10121] Expected publication date: 27 September 2021

Type

NICE guideline

Status

In development
Social, emotional and mental wellbeing in primary and secondary education

In development [GID-NG10125] Expected publication date: 10 May 2022

Type

NICE guideline

Status

In development
Integrated health and social care for people experiencing homelessness

In development [GID-NG10170] Expected publication date: 16 March 2022

Type

NICE guideline

Status

In development
Managing common infections - antimicrobial prescribing guidelines

In development [GID-NG10050] Expected publication date: TBC

Type

NICE guideline

Status

In development
Mental wellbeing at work

In development [GID-NG10140] Expected publication date: 15 December 2021

Type

NICE guideline

Status

In development
Reducing sexually transmitted infections

In development [GID-NG10142] Expected publication date: 09 February 2022

Type

NICE guideline

Status

In development
Electrohydraulic lithotripsy for difficult-to-treat bile duct stones

In development [GID-IPG10151] Expected publication date: 28 April 2021

Type

Interventional procedures guidance

Status

In development
Permanent His-bundle pacemaker implantation for heart failure

In development [GID-IPG10145] Expected publication date: 28 April 2021

Type

Interventional procedures guidance

Status

In development
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults

In development [GID-IPG10143] Expected publication date: 28 April 2021

Type

Interventional procedures guidance

Status

In development
Lung transplantation with ex-vivo perfusion

In development [GID-IP1046] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis

In development [GID-IPG10142] Expected publication date: 24 February 2021

Type

Interventional procedures guidance

Status

In development
Transvenous obliteration of varices

In development [GID-IPG10206] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Image-guided cryoablation of peripheral neuroma for chronic pain

In development [GID-IPG10208] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease

In development [GID-IPG10209] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Pharyngeal Electrical Stimulation for neurogenic dysphagia

In development [GID-IPG10212] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Trabeculectomy with biodegradable collagen matrix implant for glaucoma

In development [GID-IPG10211] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Transvaginal laser therapy for urogenital atrophy

In development [GID-IPG10155] Expected publication date: 26 May 2021

Type

Interventional procedures guidance

Status

In development
Transvaginal laser therapy for stress urinary incontinence

In development [GID-IPG10156] Expected publication date: 26 May 2021

Type

Interventional procedures guidance

Status

In development
Laser lithotripsy for difficult-to-treat bile duct stones

In development [GID-IPG10157] Expected publication date: 26 May 2021

Type

Interventional procedures guidance

Status

In development
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex - vivo lung perfusion) for transplantation

In development [GID-IPG10149] Expected publication date: 26 May 2021

Type

Interventional procedures guidance

Status

In development
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver

In development [GID-IPG10177] Expected publication date: 21 April 2021

Type

Interventional procedures guidance

Status

In development
Geniculate artery embolisation for pain from knee osteoarthritis

In development [GID-IPG10171] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Botulinum toxin injection into the urethral sphincter for idiopathic chronic non-obstructive urinary retention

In development [GID-IPG10172] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cholangiocarcinoma or pancreatic adenocarcinoma

In development [GID-IPG10067] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Self-expanding implant insertion into the intersphincteric space for faecal incontinence

In development [GID-IPG10137] Expected publication date: 27 January 2021

Type

Interventional procedures guidance

Status

In development
Transcatheter Mitral Valve In Ring (TMVIR) for treating a failing mitral valve repair

In development [GID-IPG10154] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Implanting a baroreceptor stimulation device for resistant hypertension

In development [GID-IP1180] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Radiofrequency ablation for palliation of painful spinal metastases

In development [GID-IPG10158] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development